Immunohistochemical analysis of prostate apoptosis response-4 (Par-4) in Mexican women with breast cancer: a preliminary study

Archives of Medical Research
Luis Fernando Méndez-LópezMartha Imelda Dávila-Rodríguez

Abstract

We undertook this study to compare the expression level of prostate apoptosis response-4 (Par-4) among patient outcome in two groups of women with breast cancer (short and long survival) and two groups without breast cancer (benign lesion and control). We included breast specimens with nonhistological abnormalities (eight samples) as a control group. Semiquantitative and quantitative analysis of immunohistochemical staining by image analysis software were used to study the intensity of Par-4 expression. Both methods produced similar results (p>0.05). No significant expression of Par-4 was observed in normal breast tissue. Benign lesions and breast cancer tissue showed strong nuclear expression of Par-4, predominantly on epithelial cells and specifically in ductal cells. Par-4 expression was lower in myoepithelial cells and there was no appreciable stromal staining. Significantly less Par-4 reactivity was detected in tissue from patients with a short survival compared with patients with benign lesions and those with a long survival. Our findings suggest that a lower expression level of Par-4 is related to an unfavorable prognosis. A larger prospective study of samples of all patient groups with a longer follow-up is needed to va...Continue Reading

References

Jan 1, 1992·Breast Cancer Research and Treatment·M H GaleaI O Ellis
Jan 1, 1994·Breast Cancer Research and Treatment·R M Elledge, D C Allred
Jul 1, 1997·Molecular and Cellular Biology·S F SellsV M Rangnekar
Dec 22, 1999·Oncogene·M Barkett, T D Gilmore
Mar 20, 2003·The Journal of Biological Chemistry·Sangeeta K CheemaGabriel Lopez-Berestein
Aug 5, 2003·Molecular and Cellular Biology·Nadia El-GuendyVivek M Rangnekar
Jan 20, 2005·Molecular and Cellular Biology·Sushma GurumurthyVivek M Rangnekar
May 7, 2005·EMBO Reports·Isabel García-CaoManuel Serrano
Oct 8, 2005·Molecular Cell·Anindya GoswamiVivek M Rangnekar
Mar 3, 2007·Cancer Research·Gema Moreno-BuenoJose Palacios
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Mansoor M AhmedWilliam E Strodel
Jan 20, 2010·Archives of Medical Research·Pablo Zapata-BenavidesCristina Rodriguez-Padilla

❮ Previous
Next ❯

Citations

Oct 30, 2013·Breast Cancer Research : BCR·Nikhil HebbarVivek M Rangnekar
Jun 4, 2014·Expert Opinion on Therapeutic Targets·Wu QinanChen Bing
Jun 21, 2019·Scientific Reports·Haihong GuoJörg Hartkamp
Nov 30, 2018·Cancer Causes & Control : CCC·Chunyan HeThomas C Tucker
Nov 27, 2018·Current Drug Targets·Renata Virgínia Cavalcanti SantosMichelly Cristiny Pereira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Annals of the New York Academy of Sciences
Padhma Ranganathan, Vivek M Rangnekar
Journal of Cellular Biochemistry
Robert L MargolisP R Andreassen
© 2021 Meta ULC. All rights reserved